Cardiogenic shock complicating acute myocardial infarction in the elderly: predictors of long-term survival

Francesco Tomassini1, Andrea Gagnor, Alessandro Migliardi

  • 1Department of Cardiology, Infermi Hospital, Rivoli, Italy. emodinamica@asl5.piemonte.it

Insights

Elderly patients (≥75 years) with acute myocardial infarction (AMI) and cardiogenic shock (CS) have higher mortality despite percutaneous coronary intervention (PCI). PCI failure is a key predictor of mortality in all AMI patients with CS.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Geriatric Cardiology

Background:

  • Cardiogenic shock (CS) is a severe complication of acute myocardial infarction (AMI) with high mortality.
  • Immediate coronary revascularization improves survival in AMI, but benefits in elderly patients remain unclear.
  • This study investigates outcomes in elderly AMI patients (≥75 years) with CS.

Purpose of the Study:

  • To evaluate in-hospital and long-term outcomes in elderly patients (≥75 years) experiencing AMI with CS.
  • To compare outcomes between elderly (≥75 years) and younger (<75 years) AMI patients with CS undergoing PCI.

Main Methods:

  • Data from 157 consecutive AMI patients with CS who underwent PCI were analyzed.
  • Patients were stratified into two groups: <75 years and ≥75 years old.
  • Clinical characteristics, procedural details, and in-hospital/long-term outcomes were compared.

Main Results:

  • The elderly group (≥75 years) comprised 36.9% of patients (n=58).
  • In-hospital (55% vs. 25%) and long-term (62.1% vs. 37.3%) mortality were significantly higher in the elderly group.
  • PCI failure predicted both in-hospital and long-term mortality; age ≥75 years predicted in-hospital mortality.

Conclusions:

  • Percutaneous coronary intervention (PCI) can be performed in elderly AMI patients with CS.
  • The risk associated with PCI in this elderly cohort appears acceptable and potentially lower than previously reported.
  • PCI failure is a critical determinant of mortality in AMI patients with CS, irrespective of age.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...